Lupin Buys Anti-cholesterol Take Rights For $39 Mn
Indian pharmaceuticals field Lupin today said it had acquired the rights for Antara, a take to impact broad murder cholesterin and broad triglycerides, for $38.
This entry was posted
on Tuesday, September 29th, 2009 at 1:27 pm and is filed under Live News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
Lupin Buys Anti-cholesterol Take Rights For $39 Mn
Indian pharmaceuticals field Lupin today said it had acquired the rights for Antara, a take to impact broad murder cholesterin and broad triglycerides, for $38.
This entry was posted
on Tuesday, September 29th, 2009 at 1:27 pm and is filed under Live News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
Lupin Buys Anti-cholesterol Take Rights For $39 Mn
Indian pharmaceuticals field Lupin today said it had acquired the rights for Antara, a take to impact broad murder cholesterin and broad triglycerides, for $38.
This entry was posted
on Tuesday, September 29th, 2009 at 1:27 pm and is filed under Live News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.